US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 33.150
  • +0.050+0.15%
Close May 9 16:00 ET
  • 33.080
  • -0.070-0.21%
Post 20:01 ET
13.97BMarket Cap13.53P/E (TTM)

Royalty Pharma Key Stats

Business Currency:USD
2025/Q1
Stock NameRevenueRatio
Cystic fibrosis franchise195.12M34.34%
Other products157.84M27.78%
Evrysdi51.78M9.11%
Tremfya38.13M6.71%
Trelegy34.78M6.12%
TYSABRI31.33M5.51%
Voranigo30.53M5.37%
Other royalty income and revenues28.76M5.06%
View all
Region Currency:USD
2024/FY
Stock NameRevenueRatio
United States2.26B100.00%

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More